Unavailable
Unavailable
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/25/2025 | $170.00 | Buy → Hold | HSBC Securities |
2/14/2025 | $255.00 | Overweight | Wells Fargo |
1/6/2025 | $235.00 → $280.00 | Market Perform → Outperform | Leerink Partners |
12/4/2024 | $295.00 | Outperform | Mizuho |
10/10/2024 | Hold | Needham | |
2/26/2024 | $310.00 | Market Perform | Leerink Partners |
12/11/2023 | $197.00 | Neutral → Sell | Goldman |
10/27/2023 | $200.00 | Buy → Neutral | UBS |
HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00
Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00
Leerink Partners upgraded Align Tech from Market Perform to Outperform and set a new price target of $280.00 from $235.00 previously
Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
SD - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Britt Vitalone, Executive Vice President and Chief Financial Officer ("CFO"), McKesson Corporation, to Align's Board of Directors along with its Audit Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702733967/en/Britt Vitalone (photo) "I am pleased to welcome Britt to Align's board of dire
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be
Align reinforces commitment to innovation, community and partnership with the dental profession across the Asia Pacific region Showcases latest innovations across iTero digital scanning, treatment planning and treating growing children and teens Celebrates 20 million Invisalign Smiles milestone globally and 3 million Invisalign Smiles across Asia Pacific with "20M smiles, 20M stories, endless possibilities" Adjacent Align APAC University Forum underscores importance of education, learning and partnership Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ i
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be
Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)